Applied DNA, GHCL and Reliance Industries, launch CertainT® recycled PET in Bedding Products at New York Home Fashions Week March 2018
STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced it is collaborating with GHCL, Limited (listed on NSE and BSE), a global manufacturer of home textiles, and Reliance Industries Ltd. (RIL), India’s largest private sector company and the first to feature in Fortune’s Global 500 list of ‘World’s Largest Corporations’ – to launch CertainT® verified recycled PET (“rPET”) bedding products at New York Home Fashions week, to be held from March 19 to 22, 2018.
Fully source-verified, recycled polyethylene terephthalate (PET post-consumer) is the clear plastic best known for packaging bottled water, and is the most widely recycled plastic in the world. GHCL will use Applied DNA’s CertainT platform in connection with PET- and/or recycled PET-blended bed sheets, pillowcases, and shams sold in-store or online in the United States. RIL is collaborating with GHCL and Applied DNA as the preferred fiber-manufacturing partner to use the CertainT platform for authenticity of recycled PET in bed sheets, pillowcases, and shams.
RIL, the largest integrated producer of polyester fibre and yarn in the world, manufacturers the most ecofriendly fibres in the world, Recron® Green Gold fibres and Recron® Green Gold Dope-Dyed (EcoD) Fibres & Tow, which are manufactured via ecofriendly processes of the highest standard. These fibers have been granted the "Global Recycle Standard" from the internationally recognized Control Union Certificates, Netherland.
Mr. Hemant Sharma, Sector Head - Polyester, RIL said, “RIL is the only company that has created a complete circle from creation of PET resin for making bottles, collection of discarded PET bottles, and converting them to Recron Green Gold Eco Friendly Polyester fibres for use by the downstream textile value chain that converts the fibres in to apparel and home textiles.”
Mr. Sharma continued, “Recron® Green Gold fibres and tow demonstrate the lowest carbon footprint number and meet the most stringent environmental criteria for being a green fiber. The collaboration with Applied DNA and GHCL for making forensic science based Recron® Green Gold fibre further bolsters our thrust on quality and persuasion for highest standards.”
“Consistent with global sustainability and the circular economy, we provide the first fully source-verified recycled PET bedding product line using CertainT, Applied DNA’s proprietary traceability system that tags, tests, tracks the original r-PET pellets to finished products,” said Manu Kapur, President and CEO of GHCL Home Textiles. “We produce a wide range of synthetic yarns from polyester, viscose and other high-end yarns which now utilize the CertainT system for full traceability. The ability to source and buy CertainT yarns made from verified recycled PET fiber is a unique offering that GHCL can provide to customers globally.”
GHCL operates its home textiles facility in Vapi in the state of Gujarat, India. The facility overseas the production process from spinning to weaving to finished processed fabric, which is then made into duvet sets, sheet sets, comforters, to name a few. As one of the leading manufacturers in home textiles in India, the plant boasts an annual production capacity of 36 million meters of finished fabric per annum. GHCL’s home textile products are predominantly exported worldwide to USA, UK, Australia, Canada, Germany and other European Union countries as well. On October 25, 2017, GHCL was presented with the Golden Peacock Award for Excellence in Corporate Governance in London, UK.
“CertainT does what no other system can do – we can tag every single fiber and verify them through a defined and secure supply chain through systematic sampling, testing and tracking,” said Dr. James Hayward, president and CEO of Applied DNA. “Momentum with retailers and manufacturers across a variety of textiles is growing; we are pleased to see the CertainT platform and trademark now making its way onto retail shelves this year, giving consumers what they want.”
GHCL is a well-diversified group with footprints in Chemicals, Textiles and Consumer Products segment. GHCL’s Textiles division is a vertically integrated manufacturing facility with spinning, wider-width weaving, continuous fabric processing, and cut & sew facilities for manufacturing premium quality bed linen. GHCL is one of India’s leading manufacturers of Home Textiles, with in-house spinning unit having capability to manufacture multiple varieties of 100% cotton and blended yarns at various facilities.
GHCL is known as perennial innovators in bed linen category with some of recent innovations in the category of ‘sheets’ which include the PERFECT FIT, EASYSHEET, microTWILL, CELLIANT, EXL Wrinkle Free Sheets, VERSATILE–Reversible Sheets, Soft Wash Percale and Sustainable Fibre dyed sheets.
GHCL’s Home Textiles products are predominantly exported worldwide to countries like United Kingdom, United States of America, Australia, Canada, Germany and other European Union countries as well.
About Reliance Industries
Reliance Industries (RIL) is India’s largest private sector company, with a consolidated turnover of INR 330,180 crore ($ 50.9 billion), cash profit of INR 42,800 crore ($ 6.6 billion), and net profit of INR 29,901 crore ($ 4.6 billion) for the year ended March 31, 2017. RIL is the first private sector company from India to feature in Fortune’s Global 500 list of ‘World’s Largest Corporations’ – currently ranking 203rd in terms of revenues, and 110th in terms of profits. The company stands 106th in the ‘Forbes Global 2000’ rankings for 2017 – the top-most among Indian companies. It ranks 10th in LinkedIn’s ‘Top Companies Where India Wants to Work Now’ (2017). RIL’s activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and 4G digital services.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-molecular based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our history of losses, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Source: Applied DNA Sciences, Inc.